Want to see TSE:CRRX full AI Analyst Report?
CRRX Stock Chart & Stats
C$3.38
C$0.01(0.30%)
At close: 4:00 PM EDT
C$3.38
C$0.01(0.30%)
Day’s Range― - ―
52-Week RangeC$2.93 - C$4.00
Previous CloseN/A
Volume3.46K
Average Volume (3M)71.09K
Market Cap
C$201.81M
Enterprise ValueC$291.62
Total Cash (Recent Filing)C$10.05M
Total Debt (Recent Filing)C$76.33M
Price to Earnings (P/E)7.6
Beta0.10
Next Earnings
Nov 11, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend Yield2.47%
Share Statistics
EPS (TTM)0.42
Shares Outstanding63,514,038
10 Day Avg. Volume18,484
30 Day Avg. Volume71,092
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.19
Price to Sales (P/S)0.65
P/FCF Ratio10.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$4.75Price Target Upside40.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.14
Revenue Forecast (FY)C$383.38M
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityThe return to profitability indicates that CareRx has improved operating execution and stabilized its earnings model. Sustained positive earnings provide a stronger base for reinvestment, debt service and shareholder returns, although operating margins remain modest.
Contracted Bed GrowthAdding beds through a long-term national seniors-home agreement should expand recurring prescription volumes and improve network scale. Because the contract fits CareRx’s existing institutional model, it can support durable revenue growth and operating leverage over time.
Cash Generation And DeleveragingPositive free cash flow, alongside materially lower leverage than in 2022, gives CareRx greater financial flexibility. Healthy conversion of earnings into cash can support capital needs and reduce balance-sheet risk as the company integrates additional beds.
Bears Say
Thin Operating MarginsCareRx remains profitable but has limited operating cushion. Thin margins leave earnings sensitive to wage, pharmacy, logistics and funding costs, while even modest execution or reimbursement pressure could restrict cash generation and slow deleveraging.
Ontario Funding HeadwindThe funding change is a structural reimbursement pressure rather than a temporary demand fluctuation. It will weigh on revenue and profitability through the medium term, and recovery depends on ward-room redevelopment that management does not expect until late 2027.
Reduced Liquidity And Higher Net DebtLower cash and higher net debt reduce financial flexibility, particularly while margins remain thin and Ontario funding is under pressure. Although leverage is currently manageable, sustained cash volatility could constrain investment or increase reliance on debt.
CareRx News
CRRX FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$2.93 and its highest was C$4.00 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$201.81M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Nov 11, 2026 which is in 78 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 29, 2026. The company reported C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.023 by -C$0.013.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of C$0.022 which represents an annual dividend yield of 2.47%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.04.
How many shares outstanding does CareRx have?
CareRx has 63,514,038 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of C$0.01 in its last earnings report, missing expectations of C$0.023. Following the earnings report the stock price went up 3.801%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$4.75 (40.53% Upside)
C$4.75 (40.53% Upside)
Insider Transactions
Bought Shares
Worth C$31.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.66%
12-Months-Change
Fundamentals
Return on Equity
2.47%
Trailing 12-Months
Asset Growth
11.38%
Trailing 12-Months
Company Description
CareRx
CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.
CRRX Stock 12 Month Forecast
Average Price Target
C$4.75
▲(40.53% Upside)
Technical Analysis
Extendicare
―
Nova Leap Health
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―